Moreover, after withdrawal of HCC-CM treatment, hAT-MSCs showed markedly reduced GLUT1, GPI and PKM2, but not HK2, GAPDH, PGK1 and LDHA, at the mRNA levels (Fig. 5f). The gene discussed is LDHA; the disease is hepatocellular carcinoma.